Advances in Optical Biosensors for Interleukin 6 Detection

Mary Geng^*
*Correspondence: Mary Geng, Department of Immunology, Universitat Politècnica de Catalunya, 08034 Barcelona, Spain, Email:

Introduction

Interleukin 6 (IL-6) is a pivotal cytokine in immunology and has wideranging implications in various medical fields, including immunology, oncology and inflammation research. Its precise and timely detection is crucial for understanding its role in health and disease. Recent advances in optical biosensors have contributed significantly to the accurate and sensitive detection of IL-6. These biosensors harness the principles of optical phenomena to provide real-time, label-free and high-throughput methods for IL-6 detection. This paper explores the remarkable progress made in the field of optical biosensors for IL-6 detection, delving into the innovative techniques, sensing mechanisms and their application in various domains. As we navigate the evolving landscape of IL-6 research, it is paramount to recognize the contributions of optical biosensors and their potential to revolutionize the way we study IL-6-related diseases and conditions [1].

Description

Optical biosensors represent a diverse class of analytical tools that rely on the interaction between light and biological molecules to detect specific analytes. The detection of IL-6, a critical cytokine involved in immune response and inflammation, has been significantly enhanced by recent advances in optical biosensors. These biosensors offer several notable features that make them invaluable in IL-6 detection. Optical biosensors enable real-time measurements, allowing researchers to monitor IL-6 interactions as they happen. This is particularly advantageous in immunological and clinical studies where understanding the dynamics of IL-6 is essential. Whether studying the progression of inflammatory responses or assessing IL-6 levels in real-time diagnostics, optical biosensors offer a temporal dimension to analysis. Optical biosensors are label-free, eliminating the need for complex and potentially interfering labeling procedures. This is especially relevant when working with precious or scarce samples, where any loss or alteration of analyte integrity is undesirable. The label-free nature of optical biosensors simplifies experimental protocols and minimizes potential artifacts [2,3].

Optical biosensors can achieve remarkable sensitivity, enabling the detection of IL-6 at low concentrations. This is crucial for research and diagnostics where IL-6 may be present in trace amounts but remains highly relevant. High sensitivity not only allows for a deeper understanding of IL-6 biology but also improves the early diagnosis and monitoring of IL-6-related diseases. The application of optical biosensors in IL-6 detection spans diverse fields, including immunology, oncology, inflammation research and clinical diagnostics. Researchers and clinicians alike have harnessed the capabilities of these biosensors to gain insights into disease mechanisms, explore potential therapeutic interventions and improve patient care. The versatility of optical biosensors, coupled with their sensitivity and real-time capabilities, has positioned them as a transformative technology in IL-6 research [4,5].

Conclusion

Advances in optical biosensors have redefined the landscape of IL-6 detection. These biosensors offer real-time monitoring, label-free operation and high sensitivity, making them indispensable tools in IL-6-related research across a range of scientific and medical domains. From investigating the role of IL-6 in immunology to improving the diagnosis and treatment of IL-6- associated diseases, optical biosensors have demonstrated their value. The real-time capabilities of optical biosensors provide a dynamic view of IL-6 interactions, contributing to a deeper understanding of its roles in health and disease. Their label-free operation simplifies experimental procedures and ensures the accuracy of IL-6 measurements, even in scenarios where analyte conservation is vital. Additionally, the high sensitivity of optical biosensors facilitates the detection of trace amounts of IL-6, which is particularly relevant in studies involving small sample volumes or low analyte concentrations. In conclusion, the recent progress in optical biosensors for IL-6 detection is poised to reshape how we study and address IL-6-related conditions. Their versatility and precision have made them a critical technology in IL-6 research, offering both researchers and clinicians the means to advance our knowledge of IL-6's roles in health and disease, ultimately improving patient care and therapeutic outcomes.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Alexandre, Lucile, Amel Bendali, Iago Pereiro and Madad Azimani, et al. "Modular microfluidic system for on-chip extraction, preconcentration and detection of the cytokine biomarker IL-6 in biofluid." Sci Rep 12 (2022): 9468.

   Google Scholar, Crossref, Indexed at

2. Shi, Jun, Rongfen Huo, Ningli Li and Haichuan Li, et al. "CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress." BMC Cancer 19 (2019): 1-8.

   Google Scholar, Crossref, Indexed at

3. Seki, Ekihiro and Robert F. Schwabe. "Hepatic inflammation and fibrosis: Functional links and key pathways." Hepatology 61 (2015): 1066-1079.

   Google Scholar, Crossref, Indexed at

4. Gabay, Cem. "Interleukin-6 and chronic inflammation." Arthritis Res Ther 8 (2006): 1-6.

   Google Scholar, Crossref, Indexed at

5. Metcalfe, Riley D., Tracy L. Putoczki and Michael DW Griffin. "Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: Focus on interleukin 11." Front Immunol 11 (2020): 1424.

   Google Scholar, Crossref, Indexed at